Active pharmaceutical ingredients (APIs) of medicines for human use can be released to the environment during the manufacturing process, following use by patients or when unused medicines are disposed of in an incorrect manner. As APIs are biologically active compounds, concerns have been raised about the potential effects of APIs in the environment on human […]
Active pharmaceutical ingredients (APIs) of medicines for human use can be released to the environment during the manufacturing process, following use by patients or when unused medicines are disposed of in an incorrect manner. As APIs are biologically active compounds, concerns have been raised about the potential effects of APIs in the environment on human […]
European legislation requires testing of parasiticides using, among others, dung beetles (OECD GD 122). Currently, Aphodius constans, a dweller species, has been approved as a test species for residues in dung. However, results of tests using A. constans may not be relevant for tunneler species.
Avermectin and milbemycin parasiticides have a high toxicity to non-target organisms, are often persistent and may have a potential to bioaccumulate. The present project contributes to filling gaps in the database for a complete environmental risk assessment of these parasiticides. In addition, risk management strategies for parasiticides used in pasture animals were discussed. For ivermectin […]
The final reports of two projects, ’Substances of very high concern under REACH – an evaluation of uncertainties in the environmental risk assessment of endocrine active substances‘ and ‘Review and enhancement of new risk assessment concepts under REACH‘ have been published.
Meet us at our booth or visit the following presentations:
Monday, May 12th, 2014:
Coors A., Sacher F., Juffernholz T., Drost W., Gildemeister D., Kühnen U.: Human pharmaceuticals and industrial chemicals in wastewater effluents – first steps toward a combined risk assessment
Poster session: Waste and wastewater effluents: chemical and ecotoxicological characterization
In the authorisation process of biocidal products, the joint effects of the product components (active substances and relevant additives) shall be taken into account in the environmental risk assessment according to the relevant regulatory guidance. The concept of concentration addition (CA) is the proposed default model for this assessment. Open questions in this context are […]
The aim of this project is to develop and evaluate concepts for a risk assessment of wastewater effluents taking into account the joint effects of chemicals, which are not completely eliminated in the wastewater treatment process. The focus is on pharmaceutical residues and industrial chemicals, particularly those that are frequently detected in effluents. The predictability […]
The newly proposed EFSA guidance document on risk assessment for plant protection products for aquatic organisms1 recommends the Lumbriculus test (instead of the Chironomus test) specifically for pesticides with fungicidal activity. ECT coordinated the validation ring test for the Lumbriculus OECD test guideline […]
ECT celebrated its 20th anniversary party in the Senckenberg-Museum, Frankfurt, on 22 November 2013. We thank all our guests for the great time we have had together among the dinosaurs!
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information